RxDoctor Payments Data

Brittney Dye, APRN

Acute Care · Columbus, OHNPI 1649707803

Payments from drug & device makers

$2,599in general payments, 2019–2025

Across 139 payments — averaging $18.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$636
  • Johnson & Johnson$365
  • Takeda Pharmaceuticals U.S.A., Inc.$200
  • Pfizer$171
  • Sanofi$165
  • Daiichi Sankyo Inc.$122
  • plus $940 from 15 others

What the payments were for

  • Food & beverage$2,46395%
  • Education$1365%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,599 in reported general payments places this provider in the 90th percentile of 1,101 acute care providers in Ohio.

See all acute care providers in Ohio

Medicare billing

Part B allowed, 2024
$23,984
Medicare patients
203
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$48,699
XifaxanRifaximin14$44,099
LinzessLinaclotide24$17,592
TrulancePlecanatide14$14,021
Dexlansoprazole DrDexlansoprazole15$6,128
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates96$5,833
Sucralfate47$3,416
ClenpiqSod Picosulf/Mag Ox/Citric Ac13$2,199
Omeprazole200$1,829
PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C12$1,624
Pantoprazole Sodium191$1,529
Colestipol Hcl20$1,373
Dicyclomine Hcl46$990
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl71$889
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl69$817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$636$66,29140 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance, Plenvu$97$59,74440 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,101 acute care providers in Ohio.

Other acute care in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →